PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 8734306-2 1996 RESULTS: VIP-stimulated net water flux was efficiently inhibited by both peptides at all three intestinal levels studied; PYY (ID50 about 30 pmol/kg.h) was 3 to 18 fold more potent than NPY. Water 28-33 vasoactive intestinal peptide Rattus norvegicus 9-12 9311665-3 1997 The aim of the present study was to investigate the mechanisms of the peptide YY effect on vasoactive intestinal peptide (VIP)-stimulated jejunal net water flux in the rat. Water 150-155 vasoactive intestinal peptide Rattus norvegicus 122-125 9311665-5 1997 A small peptide YY dose (10 pmol/kg) inhibited significantly (P < 0.005) the jejunal net water flux produced by 30 microg/kg per h of VIP. Water 92-97 vasoactive intestinal peptide Rattus norvegicus 137-140 9311665-7 1997 These results suggest that peptide YY inhibits VIP-stimulated jejunal net water flux in vivo through a neural mechanism implicating the participation of nicotinic synapses, alpha2-adrenoceptors and sigma receptors. Water 74-79 vasoactive intestinal peptide Rattus norvegicus 47-50 7631792-7 1995 Pretreatment of the animals with both atropine and the VIP antagonist completely abolished ileal and jejunal water secretion stimulated by cerebral TRH. Water 109-114 vasoactive intestinal peptide Rattus norvegicus 55-58 8973842-0 1996 An immunotoxin, anti-VIP antibody-ricin A chain conjugate eliminates neurons in the hypothalamic suprachiasmatic nucleus selectively and abolishes the circadian rhythm of water intake. Water 171-176 vasoactive intestinal peptide Rattus norvegicus 21-24 8973842-8 1996 These findings suggest that SCN neurons bearing VIP receptors such as AVP neurons, but not VIP neurons, may be involved in the mechanism of the circadian rhythm of water intake. Water 164-169 vasoactive intestinal peptide Rattus norvegicus 48-51 7761626-4 1995 Water movement was not affected by VIP injection in the lateral ventricle, while VIP injections in the NTS-DMN inhibited significantly (P < 0.05) jejunal water absorption by 10-12%. Water 157-162 vasoactive intestinal peptide Rattus norvegicus 81-84 7590000-5 1995 RESULTS: C7-sorbin was the minimal peptide able to decrease duodenal VIP-stimulated fluxes of water, Na and bicarbonate. Water 94-99 vasoactive intestinal peptide Rattus norvegicus 69-72 7761626-8 1995 It can be suggested that NTS-DMN complex could be a site of action of VIP since injection of VIP in it produced a more pronounced inhibitory effect on water and Ala absorption than that produced by VIP injection in the LV. Water 151-156 vasoactive intestinal peptide Rattus norvegicus 70-73 7761626-8 1995 It can be suggested that NTS-DMN complex could be a site of action of VIP since injection of VIP in it produced a more pronounced inhibitory effect on water and Ala absorption than that produced by VIP injection in the LV. Water 151-156 vasoactive intestinal peptide Rattus norvegicus 93-96 7761626-8 1995 It can be suggested that NTS-DMN complex could be a site of action of VIP since injection of VIP in it produced a more pronounced inhibitory effect on water and Ala absorption than that produced by VIP injection in the LV. Water 151-156 vasoactive intestinal peptide Rattus norvegicus 93-96 7898322-5 1994 In adrenalectomized rats given an overnight supplement of dexamethasone in their drinking water, the expression of both vasopressin and VIP mRNA in the SCN was elevated the following morning at ZT6 when compared to adrenalectomised rats kept on 0.9% saline. Water 90-95 vasoactive intestinal peptide Rattus norvegicus 136-139 35182949-8 2022 The Evans Blue leakage and brain water content were obviously reduced (P < 0.05) in vasoactive intestinal peptide-treated rats compared with those of control rats at 72 and 96 h after stroke. Water 33-38 vasoactive intestinal peptide Rattus norvegicus 84-113 8012894-1 1994 Intracerebroventricular administration of vasoactive intestinal peptide (VIP) disturbed the learning by rats of the location of a platform submerged in a water pool. Water 154-159 vasoactive intestinal peptide Rattus norvegicus 42-71 8012894-1 1994 Intracerebroventricular administration of vasoactive intestinal peptide (VIP) disturbed the learning by rats of the location of a platform submerged in a water pool. Water 154-159 vasoactive intestinal peptide Rattus norvegicus 73-76 7875437-6 1994 RESULTS: Results show that C20-sorbin and C7-sorbin decreased the VIP-stimulated net flux of water (inhibition of 40 and 37%, respectively), Na (inhibition of 31 and 30%), C1 (inhibition of 80 and 63%) and HCO3 (inhibition of 15 and 25%). Water 93-98 vasoactive intestinal peptide Rattus norvegicus 66-69 1737576-6 1992 PYY inhibited the reduction in net absorption of sodium chloride and water evoked by vasoactive intestinal peptide (VIP), but did not affect the VIP-evoked increase in net potassium secretion. Water 69-74 vasoactive intestinal peptide Rattus norvegicus 116-119 8284259-0 1993 Influence of chronic intracerebroventricular infusion of vasoactive intestinal peptide (VIP) on memory processes in Morris water pool test in the rat. Water 123-128 vasoactive intestinal peptide Rattus norvegicus 57-86 2451710-8 1988 The accumulation of water in the endoneurial compartment may be related to impaired extraction by the perineurium, to which the increased VIP content may contribute. Water 20-25 vasoactive intestinal peptide Rattus norvegicus 138-141 2886584-10 1987 However, this dose of morphine did cause a 63.5% decrease in the VIP-induced change in water transport. Water 87-92 vasoactive intestinal peptide Rattus norvegicus 65-68 3837859-1 1985 The effect of vasoactive intestinal peptide (VIP) on the intake of water was studied in the rat. Water 67-72 vasoactive intestinal peptide Rattus norvegicus 14-43 3837859-1 1985 The effect of vasoactive intestinal peptide (VIP) on the intake of water was studied in the rat. Water 67-72 vasoactive intestinal peptide Rattus norvegicus 45-48 3837859-2 1985 Intracerebroventricular administration of vasoactive intestinal peptide strongly inhibited drinking in rats deprived of water, but peripheral administration had no effect, indicating that the site of action was central. Water 120-125 vasoactive intestinal peptide Rattus norvegicus 42-71 3837859-4 1985 The results indicate that in the rat, vasoactive intestinal peptide may play a role in the control of intake of water as a neuropeptide thirst inhibitor. Water 112-117 vasoactive intestinal peptide Rattus norvegicus 38-67 6473156-1 1984 Vasoactive intestinal polypeptide (VIP) induces intestinal secretion of water and electrolytes in experimental animals and man. Water 72-77 vasoactive intestinal peptide Rattus norvegicus 35-38 31280283-8 2019 The mechanism of HSVP in regulating intestinal water metabolism in constipated rats may occur through the VIP-cAMP-PKA-AQP3 signaling pathway, and be closely related to changes in intestinal bacteria. Water 47-52 vasoactive intestinal peptide Rattus norvegicus 106-109 6646503-1 1983 Interaction of cholecystokinin (CCK) with vasoactive intestinal peptide (VIP) in body shaking response to ice-water immersion was observed in pentobarbital-anesthetized rats. Water 110-115 vasoactive intestinal peptide Rattus norvegicus 73-76 6199539-1 1983 The effects of beta-endorphin and vasoactive intestinal peptide (VIP) on the body shaking response to ice water immersion were observed in anesthetized rats. Water 106-111 vasoactive intestinal peptide Rattus norvegicus 65-68 6253842-2 1980 The effects were studied of vasoactive intestinal polypeptide (VIP), theophylline, and morphine on net water flux and cyclic adenosine 3",5"-monophosphate (cyclic AMP) levels in the jejunum of anaesthetized rats in vivo and of VIP and morphine on adenylate cyclase activity in rat epithelial cell membranes in vitro. Water 103-108 vasoactive intestinal peptide Rattus norvegicus 63-66 6253842-4 1980 Infusion of VIP (0.1-2 x 10(-9) mol/min/kg) dose dependently caused a reversal from net water absorption to net secretion; 2 x 10(-9) mol/min/kg enhanced the mucosal cyclic AMP content by 67%. Water 88-93 vasoactive intestinal peptide Rattus norvegicus 12-15 6253842-6 1980 Theophylline (5 mg/ml, intraluminally) enhanced the effect of intra-arterial infusion of VIP (2 x 10(-9) mol/min/kg) as to net water secretion and increase in mucosal cyclic AMP content. Water 127-132 vasoactive intestinal peptide Rattus norvegicus 89-92 6253842-14 1980 The finding that low doses of VIP, which already have an effect on net water flux, fail to increase cyclic AMP levels makes it likely that other mediators besides cyclic AMP are involved in the effect of VIP on net water flux. Water 215-220 vasoactive intestinal peptide Rattus norvegicus 204-207 223821-2 1979 Intravenous infusion of VIP (14.3 microgram/kg/hr) inhibited net absorption of water and electrolytes in the ileum and reversed net absorption to net secretion in the colon. Water 79-84 vasoactive intestinal peptide Rattus norvegicus 24-27 27932763-6 2016 Compared with the model group, the first black stool time in the model +VIP group was shortened, the fecal water content increased significantly (both P<0.05); the mucosal epithelium integrity improved, the number of goblet cells increased; the content of AQP3 and VIP in colon tissues was increased, and the cAMP, PKA, and AQP3 mRNA levels were elevated (all P<0.05). Water 107-112 vasoactive intestinal peptide Rattus norvegicus 72-75